Booster Therapeutics

Booster Therapeutics is a biotechnology company developing a new class of proteasome activator medicines to treat neurodegenerative and other diseases. Their DGRADX platform utilizes small molecules to activate 20S proteasomes, restoring the body's ability to clear disease-causing proteins more effectively than current targeted protein degraders. This approach aims to address complex diseases resulting from multiple concurrent proteinopathies.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $15M

Date: 10-Oct-2024

Investors: Apollo Health Ventures, Novo Holdings

Markets: Biotechnology, Pharmaceuticals, Neurodegenerative Diseases

HQ: Berlin, Berlin, Germany

Founded: 2020

Website: http://www.boostertx.com/

LinkedIn: https://www.linkedin.com/company/booster-therapeutics/

Twitter:

Instagram: